Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven to have anti-inflammatory, anti-fibrosis, antioxidant, and anti-cancer effects. The aim of this study was to explo...
Saved in:
Main Authors: | Jizhen Huang (Author), Xiang Tong (Author), Li Zhang (Author), Yuan Zhang (Author), Lei Wang (Author), Dongguang Wang (Author), Shijie Zhang (Author), Hong Fan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
by: Xiang Tong, et al.
Published: (2021) -
Fisetin Alleviated Bleomycin-Induced Pulmonary Fibrosis Partly by Rescuing Alveolar Epithelial Cells From Senescence
by: Li Zhang, et al.
Published: (2020) -
Human Endometrial Regenerative Cells Attenuate Bleomycin-Induced Pulmonary Fibrosis in Mice
by: Yiming Zhao, et al.
Published: (2018) -
Clinical Characteristics and Prognostic Analysis of Patients With Pulmonary Tuberculosis and Type 2 Diabetes Comorbidity in China: A Retrospective Analysis
by: Shijie Zhang, et al.
Published: (2021) -
Atractylodin ameliorates bleomycin-induced pulmonary inflammation and fibrosis in mice
by: Zhenhui Wu, et al.
Published: (2023)